Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy

Objective: To evaluate the cost-effectiveness of bedaquiline plus background drug regimens (BR) for multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) in Italy. Methods: A Markov model was adapted to the Italian setting to estimate the incremental cost-eff...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Luigi R. Codecasa, Mondher Toumi, Anna D’Ausilio, Andrea Aiello, Francesco Damele, Roberta Termini, Alessia Uglietti, Robert Hettle, Giorgio Graziano, Saverio De Lorenzo
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Taylor & Francis Group 2017-01-01
Cyfres:Journal of Market Access & Health Policy
Pynciau:
Bedaquiline
cost-effectiveness
MDR tuberculosis
XDR tuberculosis
Italy
Mynediad Ar-lein:http://dx.doi.org/10.1080/20016689.2017.1283105

Rhyngrwyd

http://dx.doi.org/10.1080/20016689.2017.1283105

Eitemau Tebyg